Latvian research centre offering information communication technology (ICT) of microbiome data set is looking for partners to conclude license or spin-off agreements

A Latvian research centre that is engaged in the commercialization of its own scientific and technical developments is looking for partners for license agreement or spin-off agreement for one of its technologies. It has developed bio-ICT of microbiome data set - and innovative platform where data analysis and recommendations are based on analysis models created by artificial intelligence (AI).

A long-established Latvian research centre specialized in molecular biology and biomedicine has evolved into a powerful scientific centre performing basic as well as applied research in three major directions: - molecular medicine and disease mechanisms; - cancer research; - structural biology, biotechnology and virology. The centre offer an innovative ICT platform of microbiome data set - multifunctional, cloud-based open data collection and analysis platform, where data analysis and recommendations are based on analysis models created by artificial intelligence. The ICT of microbiome platform will integrate the knowledge gained so far on the effects of intestinal microbiome on the prediction, prevention, treatment, dietary habits and health in general and is able to manage and validate microbiome analysis together with real-life data, providing evidence-based personalized recommendations, as well as ensuring the availability of microbiome data interpretation tools for various industries (food, cosmetics, pharmaceuticals, healthcare, health analysis, etc.) to improve their products/services. The centre is looking for partners for cooperation under license agreement or spin-off agreement - both SMEs and large enterprises operating in medical and especially bio-ICT field.